Index by author
September 01, 1993; Volume 21,Issue 5
A
Abbott, F S
- You have accessIdentification of carbamoylated thiol conjugates as metabolites of the antineoplastic 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea, in rats and humans.A G Borel and F S AbbottDrug Metabolism and Disposition September 1993, 21 (5) 889-901;
Abdel-Rahman, M S
- You have accessMetabolism of benzophenone-3 in rats.C S Okereke, A M Kadry, M S Abdel-Rahman, R A Davis and M A FriedmanDrug Metabolism and Disposition September 1993, 21 (5) 788-791;
Abramson, F
- You have accessDrug metabolism studies using "intrinsic" and "extrinsic" labels. A demonstration using 15N vs. Cl in midazolam.H Song and F AbramsonDrug Metabolism and Disposition September 1993, 21 (5) 868-873;
Albrecht, E
- You have accessDisposition of the 3H-labeled gonadotropin-releasing hormone analog buserelin in rats.H Berger, J Sandow, N Heinrich, E Albrecht, U Kertscher and J OehlkeDrug Metabolism and Disposition September 1993, 21 (5) 818-822;
Andrew, P D
- You have accessDisposition of sumatriptan in laboratory animals and humans.C M Dixon, D A Saynor, P D Andrew, J Oxford, A Bradbury and M H TarbitDrug Metabolism and Disposition September 1993, 21 (5) 761-769;
B
Bandyopadhyay, A M
- You have accessEffect of nutritional obesity on the induction of CYP2B enzymes following phenobarbital treatment.P N Zannikos, A M Bandyopadhyay, L W Robertson and R A BlouinDrug Metabolism and Disposition September 1993, 21 (5) 782-787;
Batt, A M
- You have accessIdentification of cytochrome P-450 isozymes involved in the hydroxylation of dantrolene by rat liver microsomes.Z Jayyosi, J Villoutreix, J M Ziegler, A M Batt, F De Maack, G Siest and P E ThomasDrug Metabolism and Disposition September 1993, 21 (5) 939-945;
Berger, H
- You have accessDisposition of the 3H-labeled gonadotropin-releasing hormone analog buserelin in rats.H Berger, J Sandow, N Heinrich, E Albrecht, U Kertscher and J OehlkeDrug Metabolism and Disposition September 1993, 21 (5) 818-822;
Bernadou, J
- You have accessModel systems for oxidative drug metabolism studies. Catalytic behavior of water-soluble metalloporphyrins depends on both the intrinsic robustness of the catalyst and the nature of substrates.M Vidal, M Bonnafous, S Defrance, P Loiseau, J Bernadou and B MeunierDrug Metabolism and Disposition September 1993, 21 (5) 811-817;
Bjorge, S M
- You have accessBioactivation and irreversible binding of the cognition activator tacrine using human and rat liver microsomal preparations. Species difference.T F Woolf, W F Pool, S M Bjorge, T Chang, O P Goel, C F Purchase, M C Schroeder, K L Kunze and W F TragerDrug Metabolism and Disposition September 1993, 21 (5) 874-882;
Blanz, J
- You have accessDetection and identification of human urinary metabolites of biantrazole (CI-941).J Blanz, U Renner, K Schmeer, G Ehninger and K P ZellerDrug Metabolism and Disposition September 1993, 21 (5) 955-961;
Blouin, R A
- You have accessEffect of nutritional obesity on the induction of CYP2B enzymes following phenobarbital treatment.P N Zannikos, A M Bandyopadhyay, L W Robertson and R A BlouinDrug Metabolism and Disposition September 1993, 21 (5) 782-787;
Bonnafous, M
- You have accessModel systems for oxidative drug metabolism studies. Catalytic behavior of water-soluble metalloporphyrins depends on both the intrinsic robustness of the catalyst and the nature of substrates.M Vidal, M Bonnafous, S Defrance, P Loiseau, J Bernadou and B MeunierDrug Metabolism and Disposition September 1993, 21 (5) 811-817;
Bopp, B A
- You have accessDifferences in the stereoselective pharmacokinetics of pazinaclone (DN-2327), a new anxiolytic, and its active metabolite after intravenous and oral single doses to dogs.Z Hussein, D J Mulford, B A Bopp and G R GrannemanDrug Metabolism and Disposition September 1993, 21 (5) 805-810;
Borel, A G
- You have accessIdentification of carbamoylated thiol conjugates as metabolites of the antineoplastic 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea, in rats and humans.A G Borel and F S AbbottDrug Metabolism and Disposition September 1993, 21 (5) 889-901;
Boudinot, F D
- You have accessPharmacokinetics and metabolism of 3'-azido-2',3'-dideoxy-5-methylcytidine in rhesus monkeys.F D Boudinot, R F Schinazi, K J Doshi, H M McClure and C K ChuDrug Metabolism and Disposition September 1993, 21 (5) 855-860;
Bradbury, A
- You have accessDisposition of sumatriptan in laboratory animals and humans.C M Dixon, D A Saynor, P D Andrew, J Oxford, A Bradbury and M H TarbitDrug Metabolism and Disposition September 1993, 21 (5) 761-769;
Burka, L T
- You have accessMetabolism and elimination of oxazepam in B6C3F1 and Swiss-Webster mice.R J Griffin and L T BurkaDrug Metabolism and Disposition September 1993, 21 (5) 918-926;
C
Cano, J P
- You have accessEffect of anticancer drugs on the glucuronidation of 3'-azido-3'-deoxythymidine in human liver microsomes.J F Rajaonarison, B Lacarelle, J Catalin, A Durand and J P CanoDrug Metabolism and Disposition September 1993, 21 (5) 823-829;
Cashman, J R
- You have accessComparison of human and rhesus monkey in vitro phase I and phase II hepatic drug metabolism activities.J C Stevens, L A Shipley, J R Cashman, M Vandenbranden and S A WrightonDrug Metabolism and Disposition September 1993, 21 (5) 753-760;
Catalin, J
- You have accessEffect of anticancer drugs on the glucuronidation of 3'-azido-3'-deoxythymidine in human liver microsomes.J F Rajaonarison, B Lacarelle, J Catalin, A Durand and J P CanoDrug Metabolism and Disposition September 1993, 21 (5) 823-829;
Chang, T
- You have accessBioactivation and irreversible binding of the cognition activator tacrine using human and rat liver microsomal preparations. Species difference.T F Woolf, W F Pool, S M Bjorge, T Chang, O P Goel, C F Purchase, M C Schroeder, K L Kunze and W F TragerDrug Metabolism and Disposition September 1993, 21 (5) 874-882;
Chauret, N
- You have accessCharacterization of verlukast metabolites arising from an epoxide intermediate produced with hepatic microsomes from beta-naphthoflavone-treated rodents (P-4501A1).D A Nicoll-Griffith, N Chauret, J A Yergey, L A Trimble, L Favreau, R Zamboni, S J Grossman, J Drey and E HeroldDrug Metabolism and Disposition September 1993, 21 (5) 861-867;
Chen, I W
- You have accessUptake of alendronate by bone tissue in hypocalcemic and hypercalcemic rats.J H Lin, I W Chen and F A DelunaDrug Metabolism and Disposition September 1993, 21 (5) 800-804;
Chiu, S H
- You have accessN-glucuronidation reactions. I. Tetrazole N-glucuronidation of selected angiotensin II receptor antagonists in hepatic microsomes from rats, dogs, monkeys, and humans.S E Huskey, R R Miller and S H ChiuDrug Metabolism and Disposition September 1993, 21 (5) 792-799;
Chou, C H
- You have accessRelationship between lipophilicity and hepatic dispersion and distribution for a homologous series of barbiturates in the isolated perfused in situ rat liver.C H Chou, A M Evans, G Fornasini and M RowlandDrug Metabolism and Disposition September 1993, 21 (5) 933-938;
Chu, C K
- You have accessPharmacokinetics and metabolism of 3'-azido-2',3'-dideoxy-5-methylcytidine in rhesus monkeys.F D Boudinot, R F Schinazi, K J Doshi, H M McClure and C K ChuDrug Metabolism and Disposition September 1993, 21 (5) 855-860;
Chung, S J
- You have accessNitrite ion is not an active intermediate in the vascular metabolism of organic nitrates and organic nitrites to nitric oxide.E A Kowaluk, S J Chung and H L FungDrug Metabolism and Disposition September 1993, 21 (5) 967-969;
Cretton, E M
- You have accessReduction of 3'-azido-2',3'-dideoxynucleosides to their 3'-amino metabolite is mediated by cytochrome P-450 and NADPH-cytochrome P-450 reductase in rat liver microsomes.E M Cretton and J P SommadossiDrug Metabolism and Disposition September 1993, 21 (5) 946-950;
Criscuoli, M
- You have accessPharmacokinetics and pharmacodynamics of idrapril in rats, dogs, and humans.M Criscuoli, A Lippi, G Mengozzi, G Sardelli, A Subissi and A GiachettiDrug Metabolism and Disposition September 1993, 21 (5) 835-840;
D
Davis, R A
- You have accessMetabolism of benzophenone-3 in rats.C S Okereke, A M Kadry, M S Abdel-Rahman, R A Davis and M A FriedmanDrug Metabolism and Disposition September 1993, 21 (5) 788-791;
Dedinas, J
- You have accessA strategy for characterization of polyethylene glycol-derivatized proteins. A mass spectrometric analysis of the attachment sites in polyethylene glycol-derivatized superoxide dismutase.M M Vestling, C M Murphy, D A Keller, C Fenselau, J Dedinas, D L Ladd and M A OlsenDrug Metabolism and Disposition September 1993, 21 (5) 911-917;
Defrance, S
- You have accessModel systems for oxidative drug metabolism studies. Catalytic behavior of water-soluble metalloporphyrins depends on both the intrinsic robustness of the catalyst and the nature of substrates.M Vidal, M Bonnafous, S Defrance, P Loiseau, J Bernadou and B MeunierDrug Metabolism and Disposition September 1993, 21 (5) 811-817;
Deluna, F A
- You have accessUptake of alendronate by bone tissue in hypocalcemic and hypercalcemic rats.J H Lin, I W Chen and F A DelunaDrug Metabolism and Disposition September 1993, 21 (5) 800-804;
De Maack, F
- You have accessIdentification of cytochrome P-450 isozymes involved in the hydroxylation of dantrolene by rat liver microsomes.Z Jayyosi, J Villoutreix, J M Ziegler, A M Batt, F De Maack, G Siest and P E ThomasDrug Metabolism and Disposition September 1993, 21 (5) 939-945;
Dixon, C M
- You have accessDisposition of sumatriptan in laboratory animals and humans.C M Dixon, D A Saynor, P D Andrew, J Oxford, A Bradbury and M H TarbitDrug Metabolism and Disposition September 1993, 21 (5) 761-769;
Doshi, K J
- You have accessPharmacokinetics and metabolism of 3'-azido-2',3'-dideoxy-5-methylcytidine in rhesus monkeys.F D Boudinot, R F Schinazi, K J Doshi, H M McClure and C K ChuDrug Metabolism and Disposition September 1993, 21 (5) 855-860;
Drey, J
- You have accessCharacterization of verlukast metabolites arising from an epoxide intermediate produced with hepatic microsomes from beta-naphthoflavone-treated rodents (P-4501A1).D A Nicoll-Griffith, N Chauret, J A Yergey, L A Trimble, L Favreau, R Zamboni, S J Grossman, J Drey and E HeroldDrug Metabolism and Disposition September 1993, 21 (5) 861-867;
Durand, A
- You have accessEffect of anticancer drugs on the glucuronidation of 3'-azido-3'-deoxythymidine in human liver microsomes.J F Rajaonarison, B Lacarelle, J Catalin, A Durand and J P CanoDrug Metabolism and Disposition September 1993, 21 (5) 823-829;
E
Ehninger, G
- You have accessDetection and identification of human urinary metabolites of biantrazole (CI-941).J Blanz, U Renner, K Schmeer, G Ehninger and K P ZellerDrug Metabolism and Disposition September 1993, 21 (5) 955-961;
Elfarra, A A
- You have accessTargeting of 6-mercaptopurine to the kidneys. Metabolism and kidney-selectivity of S-(6-purinyl)-L-cysteine analogs in rats.A A Elfarra and I Y HwangDrug Metabolism and Disposition September 1993, 21 (5) 841-845;
Evans, A M
- You have accessRelationship between lipophilicity and hepatic dispersion and distribution for a homologous series of barbiturates in the isolated perfused in situ rat liver.C H Chou, A M Evans, G Fornasini and M RowlandDrug Metabolism and Disposition September 1993, 21 (5) 933-938;
F
Faudskar, A L
- You have accessGlucuronidation as a transient intermediate metabolic step in the elimination of (-)-carbovir. Identification of (-)-carbovir-5'-O-glucuronide in rat bile.C L Zimmerman, K R Iyer, A L Faudskar and R P RemmelDrug Metabolism and Disposition September 1993, 21 (5) 902-910;
Favreau, L
- You have accessCharacterization of verlukast metabolites arising from an epoxide intermediate produced with hepatic microsomes from beta-naphthoflavone-treated rodents (P-4501A1).D A Nicoll-Griffith, N Chauret, J A Yergey, L A Trimble, L Favreau, R Zamboni, S J Grossman, J Drey and E HeroldDrug Metabolism and Disposition September 1993, 21 (5) 861-867;
Fenselau, C
- You have accessA strategy for characterization of polyethylene glycol-derivatized proteins. A mass spectrometric analysis of the attachment sites in polyethylene glycol-derivatized superoxide dismutase.M M Vestling, C M Murphy, D A Keller, C Fenselau, J Dedinas, D L Ladd and M A OlsenDrug Metabolism and Disposition September 1993, 21 (5) 911-917;
Forkert, P G
- You have accessTemporal effects of 1,1-dichloroethylene on nonprotein sulfhydryl content in murine lung and liver.P G Forkert and M MoussaDrug Metabolism and Disposition September 1993, 21 (5) 770-776;
Fornasini, G
- You have accessRelationship between lipophilicity and hepatic dispersion and distribution for a homologous series of barbiturates in the isolated perfused in situ rat liver.C H Chou, A M Evans, G Fornasini and M RowlandDrug Metabolism and Disposition September 1993, 21 (5) 933-938;
Franklin, L K
- You have accessDisposition of tirilazad (U74006F), a 21-aminosteroid, in the plasma, heart, brain, and liver of the rat.S C Laizure, L K Franklin, D G Kaiser, C L Williams, R C Stevens, P L Sanders and M MillerDrug Metabolism and Disposition September 1993, 21 (5) 951-954;
Friedman, M A
- You have accessMetabolism of benzophenone-3 in rats.C S Okereke, A M Kadry, M S Abdel-Rahman, R A Davis and M A FriedmanDrug Metabolism and Disposition September 1993, 21 (5) 788-791;
Fung, H L
- You have accessNitrite ion is not an active intermediate in the vascular metabolism of organic nitrates and organic nitrites to nitric oxide.E A Kowaluk, S J Chung and H L FungDrug Metabolism and Disposition September 1993, 21 (5) 967-969;
G
Giachetti, A
- You have accessPharmacokinetics and pharmacodynamics of idrapril in rats, dogs, and humans.M Criscuoli, A Lippi, G Mengozzi, G Sardelli, A Subissi and A GiachettiDrug Metabolism and Disposition September 1993, 21 (5) 835-840;
Goel, O P
- You have accessBioactivation and irreversible binding of the cognition activator tacrine using human and rat liver microsomal preparations. Species difference.T F Woolf, W F Pool, S M Bjorge, T Chang, O P Goel, C F Purchase, M C Schroeder, K L Kunze and W F TragerDrug Metabolism and Disposition September 1993, 21 (5) 874-882;
Granneman, G R
- You have accessDifferences in the stereoselective pharmacokinetics of pazinaclone (DN-2327), a new anxiolytic, and its active metabolite after intravenous and oral single doses to dogs.Z Hussein, D J Mulford, B A Bopp and G R GrannemanDrug Metabolism and Disposition September 1993, 21 (5) 805-810;
Griffin, R J
- You have accessMetabolism and elimination of oxazepam in B6C3F1 and Swiss-Webster mice.R J Griffin and L T BurkaDrug Metabolism and Disposition September 1993, 21 (5) 918-926;
Grossman, S J
- You have accessCharacterization of verlukast metabolites arising from an epoxide intermediate produced with hepatic microsomes from beta-naphthoflavone-treated rodents (P-4501A1).D A Nicoll-Griffith, N Chauret, J A Yergey, L A Trimble, L Favreau, R Zamboni, S J Grossman, J Drey and E HeroldDrug Metabolism and Disposition September 1993, 21 (5) 861-867;
H
Hasinoff, B B
- You have accessEnzymatic ring-opening reactions of the chiral cardioprotective agent (+) (S)-ICRF-187 and its (-) (R)-enantiomer ICRF-186 by dihydropyrimidine amidohydrolase.B B HasinoffDrug Metabolism and Disposition September 1993, 21 (5) 883-888;
Heinrich, N
- You have accessDisposition of the 3H-labeled gonadotropin-releasing hormone analog buserelin in rats.H Berger, J Sandow, N Heinrich, E Albrecht, U Kertscher and J OehlkeDrug Metabolism and Disposition September 1993, 21 (5) 818-822;
Herold, E
- You have accessCharacterization of verlukast metabolites arising from an epoxide intermediate produced with hepatic microsomes from beta-naphthoflavone-treated rodents (P-4501A1).D A Nicoll-Griffith, N Chauret, J A Yergey, L A Trimble, L Favreau, R Zamboni, S J Grossman, J Drey and E HeroldDrug Metabolism and Disposition September 1993, 21 (5) 861-867;
Horecký, J
- You have accessNG-nitro-L-arginine pharmacokinetics in rats after a single intravascular and oral dose: an appearance of secondary concentration time peaks.V K Piotrovskij, Z Kállay, K Krejcy, J Horecký, T Trnovec and G RabergerDrug Metabolism and Disposition September 1993, 21 (5) 962-964;
Huskey, S E
- You have accessN-glucuronidation reactions. I. Tetrazole N-glucuronidation of selected angiotensin II receptor antagonists in hepatic microsomes from rats, dogs, monkeys, and humans.S E Huskey, R R Miller and S H ChiuDrug Metabolism and Disposition September 1993, 21 (5) 792-799;
Hussein, Z
- You have accessDifferences in the stereoselective pharmacokinetics of pazinaclone (DN-2327), a new anxiolytic, and its active metabolite after intravenous and oral single doses to dogs.Z Hussein, D J Mulford, B A Bopp and G R GrannemanDrug Metabolism and Disposition September 1993, 21 (5) 805-810;
Hwang, I Y
- You have accessTargeting of 6-mercaptopurine to the kidneys. Metabolism and kidney-selectivity of S-(6-purinyl)-L-cysteine analogs in rats.A A Elfarra and I Y HwangDrug Metabolism and Disposition September 1993, 21 (5) 841-845;
I
Iyer, K R
- You have accessGlucuronidation as a transient intermediate metabolic step in the elimination of (-)-carbovir. Identification of (-)-carbovir-5'-O-glucuronide in rat bile.C L Zimmerman, K R Iyer, A L Faudskar and R P RemmelDrug Metabolism and Disposition September 1993, 21 (5) 902-910;
J
Jayyosi, Z
- You have accessIdentification of cytochrome P-450 isozymes involved in the hydroxylation of dantrolene by rat liver microsomes.Z Jayyosi, J Villoutreix, J M Ziegler, A M Batt, F De Maack, G Siest and P E ThomasDrug Metabolism and Disposition September 1993, 21 (5) 939-945;
K
Kadry, A M
- You have accessMetabolism of benzophenone-3 in rats.C S Okereke, A M Kadry, M S Abdel-Rahman, R A Davis and M A FriedmanDrug Metabolism and Disposition September 1993, 21 (5) 788-791;
Kaiser, D G
- You have accessDisposition of tirilazad (U74006F), a 21-aminosteroid, in the plasma, heart, brain, and liver of the rat.S C Laizure, L K Franklin, D G Kaiser, C L Williams, R C Stevens, P L Sanders and M MillerDrug Metabolism and Disposition September 1993, 21 (5) 951-954;
Kállay, Z
- You have accessNG-nitro-L-arginine pharmacokinetics in rats after a single intravascular and oral dose: an appearance of secondary concentration time peaks.V K Piotrovskij, Z Kállay, K Krejcy, J Horecký, T Trnovec and G RabergerDrug Metabolism and Disposition September 1993, 21 (5) 962-964;
Keller, D A
- You have accessA strategy for characterization of polyethylene glycol-derivatized proteins. A mass spectrometric analysis of the attachment sites in polyethylene glycol-derivatized superoxide dismutase.M M Vestling, C M Murphy, D A Keller, C Fenselau, J Dedinas, D L Ladd and M A OlsenDrug Metabolism and Disposition September 1993, 21 (5) 911-917;
Kertscher, U
- You have accessDisposition of the 3H-labeled gonadotropin-releasing hormone analog buserelin in rats.H Berger, J Sandow, N Heinrich, E Albrecht, U Kertscher and J OehlkeDrug Metabolism and Disposition September 1993, 21 (5) 818-822;
Kitada, M
- You have accessRat liver microsomal cytochrome P-450 responsible for reductive metabolism of zonisamide.H Nakasa, M Komiya, S Ohmori, T Rikihisa and M KitadaDrug Metabolism and Disposition September 1993, 21 (5) 777-781;
Komiya, M
- You have accessRat liver microsomal cytochrome P-450 responsible for reductive metabolism of zonisamide.H Nakasa, M Komiya, S Ohmori, T Rikihisa and M KitadaDrug Metabolism and Disposition September 1993, 21 (5) 777-781;
Kowaluk, E A
- You have accessNitrite ion is not an active intermediate in the vascular metabolism of organic nitrates and organic nitrites to nitric oxide.E A Kowaluk, S J Chung and H L FungDrug Metabolism and Disposition September 1993, 21 (5) 967-969;
Krejcy, K
- You have accessNG-nitro-L-arginine pharmacokinetics in rats after a single intravascular and oral dose: an appearance of secondary concentration time peaks.V K Piotrovskij, Z Kállay, K Krejcy, J Horecký, T Trnovec and G RabergerDrug Metabolism and Disposition September 1993, 21 (5) 962-964;
Kunze, K L
- You have accessBioactivation and irreversible binding of the cognition activator tacrine using human and rat liver microsomal preparations. Species difference.T F Woolf, W F Pool, S M Bjorge, T Chang, O P Goel, C F Purchase, M C Schroeder, K L Kunze and W F TragerDrug Metabolism and Disposition September 1993, 21 (5) 874-882;
Kyerematen, G A
- You have accessRates of excretion of cotinine, nicotine glucuronide, and 3-hydroxycotinine glucuronide in rat bile.M J Seaton, G A Kyerematen and E S VesellDrug Metabolism and Disposition September 1993, 21 (5) 927-932;
L
Lacarelle, B
- You have accessEffect of anticancer drugs on the glucuronidation of 3'-azido-3'-deoxythymidine in human liver microsomes.J F Rajaonarison, B Lacarelle, J Catalin, A Durand and J P CanoDrug Metabolism and Disposition September 1993, 21 (5) 823-829;
Ladd, D L
- You have accessA strategy for characterization of polyethylene glycol-derivatized proteins. A mass spectrometric analysis of the attachment sites in polyethylene glycol-derivatized superoxide dismutase.M M Vestling, C M Murphy, D A Keller, C Fenselau, J Dedinas, D L Ladd and M A OlsenDrug Metabolism and Disposition September 1993, 21 (5) 911-917;
Laizure, S C
- You have accessDisposition of tirilazad (U74006F), a 21-aminosteroid, in the plasma, heart, brain, and liver of the rat.S C Laizure, L K Franklin, D G Kaiser, C L Williams, R C Stevens, P L Sanders and M MillerDrug Metabolism and Disposition September 1993, 21 (5) 951-954;
Lhoëst, G
- You have accessIsolation and identification of a novel isomerized epoxide metabolite of FK-506 from erythromycin-induced rabbit liver microsomes.G Lhoëst, N Maton and R K VerbeeckDrug Metabolism and Disposition September 1993, 21 (5) 850-854;
Lin, J H
- You have accessUptake of alendronate by bone tissue in hypocalcemic and hypercalcemic rats.J H Lin, I W Chen and F A DelunaDrug Metabolism and Disposition September 1993, 21 (5) 800-804;
Lippi, A
- You have accessPharmacokinetics and pharmacodynamics of idrapril in rats, dogs, and humans.M Criscuoli, A Lippi, G Mengozzi, G Sardelli, A Subissi and A GiachettiDrug Metabolism and Disposition September 1993, 21 (5) 835-840;
Loiseau, P
- You have accessModel systems for oxidative drug metabolism studies. Catalytic behavior of water-soluble metalloporphyrins depends on both the intrinsic robustness of the catalyst and the nature of substrates.M Vidal, M Bonnafous, S Defrance, P Loiseau, J Bernadou and B MeunierDrug Metabolism and Disposition September 1993, 21 (5) 811-817;
M
Martell, K J
- You have accessN-acetylation polymorphism in liver and pancreas of inbred rats.K J Martell and W W WeberDrug Metabolism and Disposition September 1993, 21 (5) 965-966;
Maton, N
- You have accessIsolation and identification of a novel isomerized epoxide metabolite of FK-506 from erythromycin-induced rabbit liver microsomes.G Lhoëst, N Maton and R K VerbeeckDrug Metabolism and Disposition September 1993, 21 (5) 850-854;
McClure, H M
- You have accessPharmacokinetics and metabolism of 3'-azido-2',3'-dideoxy-5-methylcytidine in rhesus monkeys.F D Boudinot, R F Schinazi, K J Doshi, H M McClure and C K ChuDrug Metabolism and Disposition September 1993, 21 (5) 855-860;
Mengozzi, G
- You have accessPharmacokinetics and pharmacodynamics of idrapril in rats, dogs, and humans.M Criscuoli, A Lippi, G Mengozzi, G Sardelli, A Subissi and A GiachettiDrug Metabolism and Disposition September 1993, 21 (5) 835-840;
Meunier, B
- You have accessModel systems for oxidative drug metabolism studies. Catalytic behavior of water-soluble metalloporphyrins depends on both the intrinsic robustness of the catalyst and the nature of substrates.M Vidal, M Bonnafous, S Defrance, P Loiseau, J Bernadou and B MeunierDrug Metabolism and Disposition September 1993, 21 (5) 811-817;
Miller, M
- You have accessDisposition of tirilazad (U74006F), a 21-aminosteroid, in the plasma, heart, brain, and liver of the rat.S C Laizure, L K Franklin, D G Kaiser, C L Williams, R C Stevens, P L Sanders and M MillerDrug Metabolism and Disposition September 1993, 21 (5) 951-954;
Miller, R R
- You have accessN-glucuronidation reactions. I. Tetrazole N-glucuronidation of selected angiotensin II receptor antagonists in hepatic microsomes from rats, dogs, monkeys, and humans.S E Huskey, R R Miller and S H ChiuDrug Metabolism and Disposition September 1993, 21 (5) 792-799;
Moussa, M
- You have accessTemporal effects of 1,1-dichloroethylene on nonprotein sulfhydryl content in murine lung and liver.P G Forkert and M MoussaDrug Metabolism and Disposition September 1993, 21 (5) 770-776;
Mulford, D J
- You have accessDifferences in the stereoselective pharmacokinetics of pazinaclone (DN-2327), a new anxiolytic, and its active metabolite after intravenous and oral single doses to dogs.Z Hussein, D J Mulford, B A Bopp and G R GrannemanDrug Metabolism and Disposition September 1993, 21 (5) 805-810;
Murphy, C M
- You have accessA strategy for characterization of polyethylene glycol-derivatized proteins. A mass spectrometric analysis of the attachment sites in polyethylene glycol-derivatized superoxide dismutase.M M Vestling, C M Murphy, D A Keller, C Fenselau, J Dedinas, D L Ladd and M A OlsenDrug Metabolism and Disposition September 1993, 21 (5) 911-917;
N
Nakasa, H
- You have accessRat liver microsomal cytochrome P-450 responsible for reductive metabolism of zonisamide.H Nakasa, M Komiya, S Ohmori, T Rikihisa and M KitadaDrug Metabolism and Disposition September 1993, 21 (5) 777-781;
Nicoll-Griffith, D A
- You have accessCharacterization of verlukast metabolites arising from an epoxide intermediate produced with hepatic microsomes from beta-naphthoflavone-treated rodents (P-4501A1).D A Nicoll-Griffith, N Chauret, J A Yergey, L A Trimble, L Favreau, R Zamboni, S J Grossman, J Drey and E HeroldDrug Metabolism and Disposition September 1993, 21 (5) 861-867;
O
Oehlke, J
- You have accessDisposition of the 3H-labeled gonadotropin-releasing hormone analog buserelin in rats.H Berger, J Sandow, N Heinrich, E Albrecht, U Kertscher and J OehlkeDrug Metabolism and Disposition September 1993, 21 (5) 818-822;
Ohmori, S
- You have accessRat liver microsomal cytochrome P-450 responsible for reductive metabolism of zonisamide.H Nakasa, M Komiya, S Ohmori, T Rikihisa and M KitadaDrug Metabolism and Disposition September 1993, 21 (5) 777-781;
Okereke, C S
- You have accessMetabolism of benzophenone-3 in rats.C S Okereke, A M Kadry, M S Abdel-Rahman, R A Davis and M A FriedmanDrug Metabolism and Disposition September 1993, 21 (5) 788-791;
Olsen, M A
- You have accessA strategy for characterization of polyethylene glycol-derivatized proteins. A mass spectrometric analysis of the attachment sites in polyethylene glycol-derivatized superoxide dismutase.M M Vestling, C M Murphy, D A Keller, C Fenselau, J Dedinas, D L Ladd and M A OlsenDrug Metabolism and Disposition September 1993, 21 (5) 911-917;
Oxford, J
- You have accessDisposition of sumatriptan in laboratory animals and humans.C M Dixon, D A Saynor, P D Andrew, J Oxford, A Bradbury and M H TarbitDrug Metabolism and Disposition September 1993, 21 (5) 761-769;
P
Piotrovskij, V K
- You have accessNG-nitro-L-arginine pharmacokinetics in rats after a single intravascular and oral dose: an appearance of secondary concentration time peaks.V K Piotrovskij, Z Kállay, K Krejcy, J Horecký, T Trnovec and G RabergerDrug Metabolism and Disposition September 1993, 21 (5) 962-964;
Pool, W F
- You have accessBioactivation and irreversible binding of the cognition activator tacrine using human and rat liver microsomal preparations. Species difference.T F Woolf, W F Pool, S M Bjorge, T Chang, O P Goel, C F Purchase, M C Schroeder, K L Kunze and W F TragerDrug Metabolism and Disposition September 1993, 21 (5) 874-882;
Purchase, C F
- You have accessBioactivation and irreversible binding of the cognition activator tacrine using human and rat liver microsomal preparations. Species difference.T F Woolf, W F Pool, S M Bjorge, T Chang, O P Goel, C F Purchase, M C Schroeder, K L Kunze and W F TragerDrug Metabolism and Disposition September 1993, 21 (5) 874-882;
R
Raberger, G
- You have accessNG-nitro-L-arginine pharmacokinetics in rats after a single intravascular and oral dose: an appearance of secondary concentration time peaks.V K Piotrovskij, Z Kállay, K Krejcy, J Horecký, T Trnovec and G RabergerDrug Metabolism and Disposition September 1993, 21 (5) 962-964;
Rajaonarison, J F
- You have accessEffect of anticancer drugs on the glucuronidation of 3'-azido-3'-deoxythymidine in human liver microsomes.J F Rajaonarison, B Lacarelle, J Catalin, A Durand and J P CanoDrug Metabolism and Disposition September 1993, 21 (5) 823-829;
Remmel, R P
- You have accessGlucuronidation as a transient intermediate metabolic step in the elimination of (-)-carbovir. Identification of (-)-carbovir-5'-O-glucuronide in rat bile.C L Zimmerman, K R Iyer, A L Faudskar and R P RemmelDrug Metabolism and Disposition September 1993, 21 (5) 902-910;
Renner, U
- You have accessDetection and identification of human urinary metabolites of biantrazole (CI-941).J Blanz, U Renner, K Schmeer, G Ehninger and K P ZellerDrug Metabolism and Disposition September 1993, 21 (5) 955-961;
Rikihisa, T
- You have accessRat liver microsomal cytochrome P-450 responsible for reductive metabolism of zonisamide.H Nakasa, M Komiya, S Ohmori, T Rikihisa and M KitadaDrug Metabolism and Disposition September 1993, 21 (5) 777-781;
Robertson, L W
- You have accessEffect of nutritional obesity on the induction of CYP2B enzymes following phenobarbital treatment.P N Zannikos, A M Bandyopadhyay, L W Robertson and R A BlouinDrug Metabolism and Disposition September 1993, 21 (5) 782-787;
Rosenberg, D W
- You have accessPharmacokinetics of cobalt chloride and cobalt-protoporphyrin.D W RosenbergDrug Metabolism and Disposition September 1993, 21 (5) 846-849;
Rowland, M
- You have accessRelationship between lipophilicity and hepatic dispersion and distribution for a homologous series of barbiturates in the isolated perfused in situ rat liver.C H Chou, A M Evans, G Fornasini and M RowlandDrug Metabolism and Disposition September 1993, 21 (5) 933-938;
S
Sanders, P L
- You have accessDisposition of tirilazad (U74006F), a 21-aminosteroid, in the plasma, heart, brain, and liver of the rat.S C Laizure, L K Franklin, D G Kaiser, C L Williams, R C Stevens, P L Sanders and M MillerDrug Metabolism and Disposition September 1993, 21 (5) 951-954;
Sandow, J
- You have accessDisposition of the 3H-labeled gonadotropin-releasing hormone analog buserelin in rats.H Berger, J Sandow, N Heinrich, E Albrecht, U Kertscher and J OehlkeDrug Metabolism and Disposition September 1993, 21 (5) 818-822;
Sardelli, G
- You have accessPharmacokinetics and pharmacodynamics of idrapril in rats, dogs, and humans.M Criscuoli, A Lippi, G Mengozzi, G Sardelli, A Subissi and A GiachettiDrug Metabolism and Disposition September 1993, 21 (5) 835-840;
Saynor, D A
- You have accessDisposition of sumatriptan in laboratory animals and humans.C M Dixon, D A Saynor, P D Andrew, J Oxford, A Bradbury and M H TarbitDrug Metabolism and Disposition September 1993, 21 (5) 761-769;
Schinazi, R F
- You have accessPharmacokinetics and metabolism of 3'-azido-2',3'-dideoxy-5-methylcytidine in rhesus monkeys.F D Boudinot, R F Schinazi, K J Doshi, H M McClure and C K ChuDrug Metabolism and Disposition September 1993, 21 (5) 855-860;
Schmeer, K
- You have accessDetection and identification of human urinary metabolites of biantrazole (CI-941).J Blanz, U Renner, K Schmeer, G Ehninger and K P ZellerDrug Metabolism and Disposition September 1993, 21 (5) 955-961;
Schroeder, M C
- You have accessBioactivation and irreversible binding of the cognition activator tacrine using human and rat liver microsomal preparations. Species difference.T F Woolf, W F Pool, S M Bjorge, T Chang, O P Goel, C F Purchase, M C Schroeder, K L Kunze and W F TragerDrug Metabolism and Disposition September 1993, 21 (5) 874-882;
Seaton, M J
- You have accessRates of excretion of cotinine, nicotine glucuronide, and 3-hydroxycotinine glucuronide in rat bile.M J Seaton, G A Kyerematen and E S VesellDrug Metabolism and Disposition September 1993, 21 (5) 927-932;
Shear, N H
- You have accessN-chlorination of sulfamethoxazole and dapsone by the myeloperoxidase system.J P Uetrecht, N H Shear and N ZahidDrug Metabolism and Disposition September 1993, 21 (5) 830-834;
Shipley, L A
- You have accessComparison of human and rhesus monkey in vitro phase I and phase II hepatic drug metabolism activities.J C Stevens, L A Shipley, J R Cashman, M Vandenbranden and S A WrightonDrug Metabolism and Disposition September 1993, 21 (5) 753-760;
Siest, G
- You have accessIdentification of cytochrome P-450 isozymes involved in the hydroxylation of dantrolene by rat liver microsomes.Z Jayyosi, J Villoutreix, J M Ziegler, A M Batt, F De Maack, G Siest and P E ThomasDrug Metabolism and Disposition September 1993, 21 (5) 939-945;
Sommadossi, J P
- You have accessReduction of 3'-azido-2',3'-dideoxynucleosides to their 3'-amino metabolite is mediated by cytochrome P-450 and NADPH-cytochrome P-450 reductase in rat liver microsomes.E M Cretton and J P SommadossiDrug Metabolism and Disposition September 1993, 21 (5) 946-950;
Song, H
- You have accessDrug metabolism studies using "intrinsic" and "extrinsic" labels. A demonstration using 15N vs. Cl in midazolam.H Song and F AbramsonDrug Metabolism and Disposition September 1993, 21 (5) 868-873;
Stevens, J C
- You have accessComparison of human and rhesus monkey in vitro phase I and phase II hepatic drug metabolism activities.J C Stevens, L A Shipley, J R Cashman, M Vandenbranden and S A WrightonDrug Metabolism and Disposition September 1993, 21 (5) 753-760;
Stevens, R C
- You have accessDisposition of tirilazad (U74006F), a 21-aminosteroid, in the plasma, heart, brain, and liver of the rat.S C Laizure, L K Franklin, D G Kaiser, C L Williams, R C Stevens, P L Sanders and M MillerDrug Metabolism and Disposition September 1993, 21 (5) 951-954;
Subissi, A
- You have accessPharmacokinetics and pharmacodynamics of idrapril in rats, dogs, and humans.M Criscuoli, A Lippi, G Mengozzi, G Sardelli, A Subissi and A GiachettiDrug Metabolism and Disposition September 1993, 21 (5) 835-840;
T
Tarbit, M H
- You have accessDisposition of sumatriptan in laboratory animals and humans.C M Dixon, D A Saynor, P D Andrew, J Oxford, A Bradbury and M H TarbitDrug Metabolism and Disposition September 1993, 21 (5) 761-769;
Thomas, P E
- You have accessIdentification of cytochrome P-450 isozymes involved in the hydroxylation of dantrolene by rat liver microsomes.Z Jayyosi, J Villoutreix, J M Ziegler, A M Batt, F De Maack, G Siest and P E ThomasDrug Metabolism and Disposition September 1993, 21 (5) 939-945;
Trager, W F
- You have accessBioactivation and irreversible binding of the cognition activator tacrine using human and rat liver microsomal preparations. Species difference.T F Woolf, W F Pool, S M Bjorge, T Chang, O P Goel, C F Purchase, M C Schroeder, K L Kunze and W F TragerDrug Metabolism and Disposition September 1993, 21 (5) 874-882;
Trimble, L A
- You have accessCharacterization of verlukast metabolites arising from an epoxide intermediate produced with hepatic microsomes from beta-naphthoflavone-treated rodents (P-4501A1).D A Nicoll-Griffith, N Chauret, J A Yergey, L A Trimble, L Favreau, R Zamboni, S J Grossman, J Drey and E HeroldDrug Metabolism and Disposition September 1993, 21 (5) 861-867;
Trnovec, T
- You have accessNG-nitro-L-arginine pharmacokinetics in rats after a single intravascular and oral dose: an appearance of secondary concentration time peaks.V K Piotrovskij, Z Kállay, K Krejcy, J Horecký, T Trnovec and G RabergerDrug Metabolism and Disposition September 1993, 21 (5) 962-964;
U
Uetrecht, J P
- You have accessN-chlorination of sulfamethoxazole and dapsone by the myeloperoxidase system.J P Uetrecht, N H Shear and N ZahidDrug Metabolism and Disposition September 1993, 21 (5) 830-834;
V
Vandenbranden, M
- You have accessComparison of human and rhesus monkey in vitro phase I and phase II hepatic drug metabolism activities.J C Stevens, L A Shipley, J R Cashman, M Vandenbranden and S A WrightonDrug Metabolism and Disposition September 1993, 21 (5) 753-760;
Verbeeck, R K
- You have accessIsolation and identification of a novel isomerized epoxide metabolite of FK-506 from erythromycin-induced rabbit liver microsomes.G Lhoëst, N Maton and R K VerbeeckDrug Metabolism and Disposition September 1993, 21 (5) 850-854;
Vesell, E S
- You have accessRates of excretion of cotinine, nicotine glucuronide, and 3-hydroxycotinine glucuronide in rat bile.M J Seaton, G A Kyerematen and E S VesellDrug Metabolism and Disposition September 1993, 21 (5) 927-932;
Vestling, M M
- You have accessA strategy for characterization of polyethylene glycol-derivatized proteins. A mass spectrometric analysis of the attachment sites in polyethylene glycol-derivatized superoxide dismutase.M M Vestling, C M Murphy, D A Keller, C Fenselau, J Dedinas, D L Ladd and M A OlsenDrug Metabolism and Disposition September 1993, 21 (5) 911-917;
Vidal, M
- You have accessModel systems for oxidative drug metabolism studies. Catalytic behavior of water-soluble metalloporphyrins depends on both the intrinsic robustness of the catalyst and the nature of substrates.M Vidal, M Bonnafous, S Defrance, P Loiseau, J Bernadou and B MeunierDrug Metabolism and Disposition September 1993, 21 (5) 811-817;
Villoutreix, J
- You have accessIdentification of cytochrome P-450 isozymes involved in the hydroxylation of dantrolene by rat liver microsomes.Z Jayyosi, J Villoutreix, J M Ziegler, A M Batt, F De Maack, G Siest and P E ThomasDrug Metabolism and Disposition September 1993, 21 (5) 939-945;
W
Weber, W W
- You have accessN-acetylation polymorphism in liver and pancreas of inbred rats.K J Martell and W W WeberDrug Metabolism and Disposition September 1993, 21 (5) 965-966;
Williams, C L
- You have accessDisposition of tirilazad (U74006F), a 21-aminosteroid, in the plasma, heart, brain, and liver of the rat.S C Laizure, L K Franklin, D G Kaiser, C L Williams, R C Stevens, P L Sanders and M MillerDrug Metabolism and Disposition September 1993, 21 (5) 951-954;
Woolf, T F
- You have accessBioactivation and irreversible binding of the cognition activator tacrine using human and rat liver microsomal preparations. Species difference.T F Woolf, W F Pool, S M Bjorge, T Chang, O P Goel, C F Purchase, M C Schroeder, K L Kunze and W F TragerDrug Metabolism and Disposition September 1993, 21 (5) 874-882;
Wrighton, S A
- You have accessComparison of human and rhesus monkey in vitro phase I and phase II hepatic drug metabolism activities.J C Stevens, L A Shipley, J R Cashman, M Vandenbranden and S A WrightonDrug Metabolism and Disposition September 1993, 21 (5) 753-760;
Y
Yergey, J A
- You have accessCharacterization of verlukast metabolites arising from an epoxide intermediate produced with hepatic microsomes from beta-naphthoflavone-treated rodents (P-4501A1).D A Nicoll-Griffith, N Chauret, J A Yergey, L A Trimble, L Favreau, R Zamboni, S J Grossman, J Drey and E HeroldDrug Metabolism and Disposition September 1993, 21 (5) 861-867;
Z
Zahid, N
- You have accessN-chlorination of sulfamethoxazole and dapsone by the myeloperoxidase system.J P Uetrecht, N H Shear and N ZahidDrug Metabolism and Disposition September 1993, 21 (5) 830-834;
Zamboni, R
- You have accessCharacterization of verlukast metabolites arising from an epoxide intermediate produced with hepatic microsomes from beta-naphthoflavone-treated rodents (P-4501A1).D A Nicoll-Griffith, N Chauret, J A Yergey, L A Trimble, L Favreau, R Zamboni, S J Grossman, J Drey and E HeroldDrug Metabolism and Disposition September 1993, 21 (5) 861-867;
Zannikos, P N
- You have accessEffect of nutritional obesity on the induction of CYP2B enzymes following phenobarbital treatment.P N Zannikos, A M Bandyopadhyay, L W Robertson and R A BlouinDrug Metabolism and Disposition September 1993, 21 (5) 782-787;
Zeller, K P
- You have accessDetection and identification of human urinary metabolites of biantrazole (CI-941).J Blanz, U Renner, K Schmeer, G Ehninger and K P ZellerDrug Metabolism and Disposition September 1993, 21 (5) 955-961;
Ziegler, J M
- You have accessIdentification of cytochrome P-450 isozymes involved in the hydroxylation of dantrolene by rat liver microsomes.Z Jayyosi, J Villoutreix, J M Ziegler, A M Batt, F De Maack, G Siest and P E ThomasDrug Metabolism and Disposition September 1993, 21 (5) 939-945;
Zimmerman, C L
- You have accessGlucuronidation as a transient intermediate metabolic step in the elimination of (-)-carbovir. Identification of (-)-carbovir-5'-O-glucuronide in rat bile.C L Zimmerman, K R Iyer, A L Faudskar and R P RemmelDrug Metabolism and Disposition September 1993, 21 (5) 902-910;